DEVELOPMENT AND MANUFACTURE OF MICROBIAL-DERIVED BIOPHARMACEUTICALS
Richter BioLogics is a leading and steadily growing biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with three cGMP-compliant manufacturing facilities in Germany.
We specialize in products derived from bacteria and yeasts. Over the past 35+ years we gained substantial experience in the development and manufacture of product types that include recombinant proteins and peptides, antibody-like scaffolds (VHH/ Nanobodies, Fab fragments), plasmid DNA, and bacterial vaccines.
We move our clients projects forward: flexible, transparent, fast
Our Expertise
- Strong track record in microbial production of biopharmaceuticals
- Specialized in products derived from bacteria and yeasts
- Customer base includes established large pharmaceutical companies, small- and mid size pharma and biotech companies worldwide
- Production of commercial and both early- and late-stage products
- Project Management
- Strain-/ Process- and Analytical Development
- Bioassay development
Our Microbial Capabilities
- Headquarters in Hamburg and three GMP-compliant manufacturing facilities in Hannover and Bovenau, Germany
- GMP facilities approved by major regulatory bodies including EMA, FDA, PMDA, ANVISA, and MFDS
- Flexible production capabilities with fermenter volumes from 10L to 1500L and suitable DSP capacities
- Batch and fed-batch manufacture
- Methanol feeding for Pichia expression
- Continuous expansion of process development and quality control capacities at all sites
- Expansion of production capacities
Our company in numbers
Employees at three facilities
+
0
max fermenter volume at Hannover
0
max fermenter volume at Bovenau
0
m² of total production area
0